Work

[Fetal safety profile of drugs used in the treatment of inflammatory rheumatic diseases].

Year: 2007

Type: article

Abstract: The high prevalence of inflammatory rheumatic diseases in women of childbearing age increases the risk of exposure to antirheumatic agents during conception pregnancy and breast feeding. The decision for pharmacological treatment initiation maintenance should be the result between the severity of maternal disease and the risk benefits with treatment. The aim of this paper was to review recent literature about drug fetal safety profile strength the importance of monitoring the pregnancy in patients with inflammatory rheumatic diseases and stress the need for further research in this area.

Source: PubMed

Authors: Sandra Falcão, Ana Filipa Mourão, J Bravo Pimentão, Jaime C Branco

Institutions: Hospital de Egas Moniz, Centro Hospitalar de Lisboa Ocidental

Language: Portuguese

Topic: Pregnancy and Medication Impact

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2410487548

FWCI:

Cites:

Cited by:

Related to: 10